Emerging Technology Insider
TechTalks: A conversation with Richard Schumacher, CEO of Pressure BioSciences
Updated: Mar 15
Richard Schumacher, CEO of Pressure BioSciences (OTCQB PBIO) discusses the impact on the company of its March 1, 2023 news release, Pressure BioSciences Announces the Exchange of Over $10 Million of Debt into Equity."
To read the news releases mentioned in the conversation go to: https://ir.pressurebiosciences.com/press-releases
Pressure BioSciences website: https://pressurebiosciences.com
About Pressure BioSciences
Pressure BioSciences, Inc. ( OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired, patented technology from BaroFold, Inc. (the "BaroFold" technology) to allow entry into the bio-pharma contract services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology ("UST") platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.
Source: Pressure BioSciences
TechTalks is a production of Emerging Technology Insider, a program of FC Global Strategies.
Emerging Technology Insider website: https://emergingtechnologyinsider.com
FC Global Strategies website: https://fcglobalstrategies.com